Humanitarian Award to support HMHB: Burnet Institute
19 February, 2020 Image: Mark Sullivan (left) with Burnet Institute Director and CEO, Professor Brendan Crabb AC Two pioneering Australians, acknowledged for their contribution to end the debilitating disease river blindness, have generously dedicated the prize money from…
Male fertility: The biological clock ticks for men, too, and affects IVF success
18 February 2020 From Monash University’s LENS Professor Beverley Vollenhoven is talking about making babies. She’s a fertility expert from Monash IVF, and Monash University’s deputy head of obstetrics and gynaecology. Usually in her line of work she’s…
Overseas grant pivotal to scientist’s immune therapy project
17 February 2020 Expertise, 20 years of experience in her field and a left-of-field idea have helped Monash Biomedicine Discovery Institute (BDI) Associate Professor Meredith O’Keeffe gain a $500,000 Worldwide Cancer Research grant. The grant, spread over three years and…
Novel stem cell approach restores motor function in Parkinson’s Disease
20 February 2020 In a remarkable approach to combatting neurodegeneration using stem cells, Florey researchers have achieved preclinical evidence that stem cells grafts can restore motor function in animals with Parkinson’s Disease. Led by Professor Clare Parish, Head…
New report on stimulating business innovation investment
20 February 2020 Modern Australian businesses are diversifying their approach to innovation, beyond research and development (R&D). These businesses experience higher revenue and job growth and are more likely to survive, says the Stimulating Business Investment in Innovation…
‘Eureka LIVE’ offers exclusive access to global Medtronic network for local companies: Medtronic seeking partners in innovation
20 February 2020 Note: Due to COVID-19 AusMedTech (and Eureka Live) has been postponed until May 2021. Sydney – 20 February 2020 – Medtronic Australasia is calling for companies across Australia and New Zealand to apply to Eureka…
Immutep Reports Positive TACTI-002 Data
19 February 2020 SYDNEY, AUSTRALIA – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces interim data from its ongoing Phase II TACTI-002 study.…
Message from the Chair of BioMelbourne Network
18 February 2020 The Board of BioMelbourne Network advises members and stakeholders that our Chief Executive Officer, Dr Julie-Anne White, has given notice of her resignation. Julie will assist in the transition and hand-over to an interim CEO,…
Test measures immune response to improve ovarian cancer diagnosis
17 February 2020 Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer. Ovarian cancer is one of the most common gynaecologic cancers, with the highest mortality rate. About…
SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide
17 February 2020 Adelaide, South Australia Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by…
Erectile Dysfunction a Potential Target for Exopharm’s Exosomes
14 February 2020 An Australian-developed regenerative therapy is exploring the possibility of a treatment for Erectile dysfunction (ED) through stimulating the regenerative and healing capacities of the body. Exopharm Limited (ASX: EX1) has been testing its exosomes –…
The 3-D printed healthcare revolution
12 February 2020 By Michelle Wheeler, freelance science journalist, for Particle Need brain surgery? We’ll get printing now. Imagine you need a complicated and risky operation to insert an implant into your brain. The implant has been custom…
